Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 10Thoracic 2Other hematologic neoplasm 2Gynecologic 2Genitourinary 2Endocrine 2Plasma cell 1Myeloid 1Lymphoid 1Head & Neck 1Classical hematology 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 354Lymphoma 306Lymphoma, Follicular 268Lymphoma, Non-Hodgkin 170Leukemia 138Hodgkin Disease 135Multiple Myeloma 130Leukemia, Lymphocytic, Chronic, B-Cell 110Lymphoma, Large B-Cell, Diffuse 108Leukemia, Myeloid, Acute 98Neoplasms 83Lymphoma, Mantle-Cell 70Burkitt Lymphoma 70Myelodysplastic Syndromes 64Breast Neoplasms 62Lymphoma, T-Cell, Cutaneous 60Lymphoma, B-Cell, Marginal Zone 59Myeloproliferative Disorders 50Mycosis Fungoides 50Motor Activity 49Lymphoma, Large-Cell, Immunoblastic 47Sezary Syndrome 44Neoplasms, Plasma Cell 42Hematologic Neoplasms 41Dementia 41Primary Myelofibrosis 39Leukemia, Myeloid, Chronic-Phase 38Leukemia, Myeloid, Accelerated Phase 38Congenital Abnormalities 38Recurrence 37

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Treatment Adherence and Compliance × Lymphoid × Clear all
NCT05260203 2024-11-06

MargheRITA

Advice Pharma Group srl

Phase NA Completed
124 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Treatment Adherence and Compliance, Amyloidosis, Anemia, Refractory, with Excess of Blasts, Hodgkin Disease, Multiple Myeloma, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, B-Cell, Lymphoma, T-Cell, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡